ALLON THERAPEUTICS INC.

Highlights Allon Therapeutics Inc.

Equities

NPCU.F

CA0197741089

Market Closed - OTC Markets Other stock markets 14:46:36 2024-03-25 EDT			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		-.--%	+9,900.00%

2013	Paladin Labs Inc. completed the acquisition of substantially all assets from Allon Therapeutics, Inc..	CI
2013	Paladin Labs Inc. signed a non-binding term sheet to acquire substantially all assets from Allon Therapeutics, Inc. for CAD 0.9 million.	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Paladin Labs Inc. completed the acquisition of substantially all assets from Allon Therapeutics, Inc..	13-07-16	CI
Paladin Labs Inc. signed a non-binding term sheet to acquire substantially all assets from Allon Therapeutics, Inc. for CAD 0.9 million.	13-05-30	CI
The United States, New Zealand & Mexico Issue Patent for New Allon Therapeutics, Inc. Platform	12-12-05	CI
Allon Therapeutics, Inc. Completes Patient Treatment in Pivotal Trial Evaluating Allon's Davunetide	12-11-13	CI
Allon Therapeutics, Inc. Receives U.S. Patent for Neurotoxicity Technology Platform in the Treatment of Peripheral Neuropathy	12-03-28	CI
Allon Therapeutics, Inc. Advances Parkinson's Disease Program	12-03-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer